MIME symposium 2025

Event Name MIME symposium 2025
Start Date Nov 20, 2025 12:45 pm
End Date Nov 20, 2025 6:00 pm
Duration 5 hours and 15 minutes
Description

Venue: Monash University, Ground Floor, 553 St Kilda Road, Melbourne

Focus: From the bedside to bench to business

DOWNLOAD PROGRAM

REGISTER

Introducing our keynote speaker: Dr Fiona Brownfoot is a specialist obstetrician at the Mercy Hospital for Women, a clinician scientist at The University of Melbourne and Co-Founder of Kali Healthcare, an AI wearable for pregnancy monitoring.

As keynote speaker, Fiona will highlight the challenges she faces daily in her clinical work, and how she decided to do something really impactful to overcome them.

Fiona's research and clinical work spans a range of areas in developing novel treatments for obstetric conditions, and devices to make pregnancy safer. Highlighting this is co-founding Kali Healthcare, where Fiona leads a multidisciplinary team of biomedical scientists and engineers to develop Kali's lead product, an innovative device to detect fetal distress during pregnancy and labour. Fiona and her team have attracted several million dollars of funding to commercialise Kali's fetal monitoring device, and are currently conducting clinical trials towards seeking FDA and TGA approval.

Introducing our Chairs and panellists: 

Professor Terry O’Brien

Terry is a world-renowned, multi award-winning consultant neurologist and researcher and has supervised hundreds of doctoral, masters, honours/medical students, clinical epilepsy fellows and post-doctoral research fellows. He is Chair of Medicine (Neurology) and Head of The School of Translational Medicine, Monash University, and Program Director Alfred Brain and Deputy Director of Research, Alfred Health. Terry is the former Van Cleef Roet Chair of Neuroscience, Monash University (2017-20) and James Stewart Chair of Medicine, The Royal Melbourne Hospital, University of Melbourne (2008-2017).

Dr Martin Nguyen

Martin is an anaesthetist, specialising in orthopaedic, thoracic, general and upper gastrointestinal, plastic, urology, ear, nose and throat, and paediatric surgery. He is also a clinician innovator who has a deep passion for solving complex problems in healthcare using technology. Through this work he has founded a number of healthcare related companies such as Medical Pantry, Medrun and WeRoster. He also gives back to fellow innovators through advisory work, mentorship and investment in startups.

Dr Liam Mahony

Liam is a Melbourne-based MedTech innovator and medical doctor. He was inspired to become a MedTech entrepreneur and innovator through being personally affected by the life-threatening condition of anaphylaxis, and persistent challenge of always having emergency adrenaline on hand via cumbersome ‘epi-pens’. This personal experience, coupled with observations of this widespread problem during clinical work, was the inspiration that led Liam to co-found his company, AdraCard.

Paul Clark

Paul has over 30 years’ experience in the international medical device industry, working in regulatory affairs, quality management, clinical research, operations and country management. He has worked for regulatory agencies in Australia, Canada, US and Europe, and as a senior manager with start-up and medium sized device companies. His experience spans a range of active and non-active device technologies, including renal, cardiovascular, ophthalmic, drug delivery, gastrointestinal, intensive care, wound care, active implantables and monitoring devices.

Roksan Libinaki, PhD

Roksan joined Avecho Biotechnology in 2001 and is currently Chief Operating Officer. Through her various roles with Avecho, Roksan has been involved and managed numerous, pre-clinical and clinical development programs with a focus on oral drug delivery systems and drug enhancement platforms to improve bioavailability and/or efficacy of a range of nutrients, and drug activities, for the purpose of improving health and well-being for both humans and animals. Roksan also completed a Global Executive MBA at the Monash Business School and leverages this experience to consult to MIME through our MedTech Commercialisation Advancement Program.

Julie Dao, PhD

Julie completed her PhD at Monash University in 2024, focused on combating the burden of cardiovascular disease. In parallel, Julie established and proactively pursued her passion for achieving impact using medical technology and biomedical innovation to co-found her company, Sonorous. Julie is the Academic Advisor for Monash Young MedTech Innovators (MYMI), Head of Innovation of Medical Pantry and leads MIME’s Invent Student Internship program. This work also collectively combines her passion to mentor future innovators to pursue the same mission to overcome major healthcare challenges.

Matthew Hoskin

Matthew is a board director, executive, and MedTech development and commercialisation expert with 30 years of experience managing businesses in the healthcare, MedTech & biotech sectors, including Siemens Medical, Vision Biosystems, Leica Biosystems, Hospira, and Sienna Cancer Diagnostics. He has led small start-ups as well as large multinationals, and has been through and managed multiple mergers and acquisitions both from the acquired and acquiring company perspectives. Developing products from hardware devices, software, automation systems, and diagnostic assays, he has taken products from research, development, manufacturing, regulatory approval, reimbursement, all the way through to global market launch.

Chris Carter

Chris is a senior executive and advisor with over 25 years of international MedTech commercialisation experience working with start-ups through to multinationals corporations. He has led the market introduction of a range of new products including first in class technologies in major global markets with a particular focus on surgical devices, endoscopy and imaging. Chris has worked in a broad range of disease areas including urology, gynaecology, ENT and hepatobillary surgery. He specialises in business strategy for product development during early stage development through to on-market products.